Skip to main content

Table 3 Mean health-related quality of life at the end of the intervention (12 months) and at 18-month follow-up and the QALYs for the intervention and the control group

From: Cost-effectiveness of the SLIMMER diabetes prevention intervention in Dutch primary health care: economic evaluation from a randomised controlled trial

 

Intervention (n = 145)

Control (n = 143)

Mean difference

Mean (SD)

Mean (SD)

Mean (95% CI)

SF-6D health status

 Baseline

0.79 (0.12)

0.79 (0.10)

−0.001 (−0.03; 0.02)

 12 months

0.81 (0.11)

0.79 (0.11)

0.02 (− 0.002; 0.05)

 18 months

0.80 (0.13)

0.79 (0.12)

0.01 (−0.02; 0.04)

QALY total over 18 months

1.20 (0.15)

1.19 (0.14)

0.02 (−0.01; 0.05)